Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : ICOM: Investment Discussion -- Ignore unavailable to you. Want to Upgrade?

To: james d. hargrave who wrote (264)	10/1/1998 12:49:00 PM
From: james d. hargrave	Read Replies (1) \| Respond to of 494

I guess this answers my DNA question! Intelect Announces $1 Million in Orders for New Digital Signal Processing Products RICHARDSON, Texas, Oct. 1 /PRNewswire/ -- Intelect Communications, Inc. (Nasdaq: ICOM - news), a leading provider of products and services for the seamless integration of voice, data and video technologies, today announced its DSP (Digital Signal Processing) Design Center is experiencing rising sales for existing products and increasing demand for new hardware and software designs. New DSP hardware orders totaling $1 million are expected to be shipped over the next two quarters and are in addition to recently announced OEM contracts. ''DNA Enterprises continues to expand as a high growth and value component of Intelect, while we are building momentum in our SONETLYNX(TM) product line away from Far East markets and are establishing our video product line for large scale deployment in corporate networks and higher bandwidth Internet applications,'' stated Herman Frietsch, Intelect Communication's chairman and chief executive officer. ''DNA's design and development expertise make it a leading resource for the global telecommunications industry and a technology bank for Intelect. DNA's engineering services are steadily profitable. Productization of DNA's DSP capabilities is adding revenues and profits, as well as prospects for a multiyear royalty income stream.'' ''We are seeing a strong ramp in our DSP business,'' stated Dr. R. Eugene Helms, president and chief executive officer of DNA Enterprises, Intelect's business unit that operates the DSP Design Center. ''These new orders are a clear indication of the mounting strength in this business and reinforces our belief that DSP will be a major contributor for us in 1999. We are particularly encouraged by this early success in light of how new the Texas Instruments C6000 DSP processor is. We anticipate that the commencement of volume production of this revolutionary line of DSPs by Texas Instruments (NYSE: TXN - news) next year will drive significant growth in our hardware sales as well as royalties from licensed products.'' ''DNA began shipments of its C6000-based products in April and we've seen a steady increase in interest since introduction,'' Dr. Helms said. ''Our industry-leading quad C6201 fixed-point processor board has been extremely well received in the market. Pentek, Inc., our primary sales channel partner for this product, has been aggressive in its advertising and has experienced notable success in selling it into applications that include high performance image processing, wireless base stations, and intelligence gathering. Sales have taken place throughout North America and Europe and have been to such companies as Siemens, Lockheed, Nortel, National Security Agency, Textron, and Jet Propulsion Laboratories. We've just expanded our relationship with Pentek to include our new quad C6701 board slated for availability in early 1999 as TI begins to supply this new floating-point processor. Due to the breadth of applications our new product targets, we expect it to quickly surpass the existing product in future sales. I foresee a tremendous opportunity emerging as this floating-point DSP rolls into production next year.'' ''Our strategic relationship with Texas Instruments continues to grow and pay dividends to us on many fronts. The C6201 evaluation module we designed for TI was launched early in the second quarter and has been a resounding success. In the wake of this program, DNA is now embarking on the design of the C6701 evaluation module under contract to TI, which is scheduled for release in January. This represents the third product we've been contracted to design for TI based on the C6000 family and further solidifies our relationship with them. DNA conducted training seminars for TI technical support personnel on the C6000 products during the summer and we have recently formalized our role with them as backup to their hotline technical support staff. This serves to expose us not only to a wide range of technical issues concerning the C6000 line, but also to a broad array of TI customers, each of whom is a prospect for our products and services. ''Initial interest has been strong for ASP6x, our unique high performance operating system designed specifically for the C6000 processor family. To date, we have supplied over 100 developer's kits to aid a wide variety of applications development efforts around the globe. Over half of our customers for this real-time operation system are in foreign locales and reports from the field indicate this product is highly useful in developing their various applications. We expect ASP6x to serve as an effective pull-through mechanism for future hardware sales and to generate on-going royalties when developers move into the production stage with their systems. ASP6x was highlighted recently as DNA worked closely with TI engineers to showcase interoperability of ASP6x with TI's Code Composer Studio software product. This was demonstrated in the TI booth at the DSP World conference held September 14-16 in Toronto. ''At this juncture, progress on the DSP front is on plan to emerge as a significant component of our business. We have strategic partnerships in place and industry-leading products that position us ideally to capitalize on the coming wave of adoption of TI's new DSP processor line as they ramp up their production next year. We have spent much of the last eighteen months positioning ourselves for 1999 and our recent successes reinforce this strategy,'' concluded Dr. Helms.